eventual aids vaccine failure rhesus monkey viral escape cytotoxic t lymphocytes 
potent virus-specific cytotoxic t lymphocyte ctl responses elicited candidate aids vaccines recently shown control viral replication prevent clinical disease progression pathogenic viral challenges rhesus monkeys- show viral escape ctl recognition can result eventual failure partial immune protection viral mutations escape ctl recognition previously described humans infected human immunodeficiency virus hiv- monkeys infected simian immunodeficiency virus siv- cohort rhesus monkeys vaccinated subsequently infected pathogenic hybrid simian-human immunodeficiency virus shiv frequency viral sequence mutations within ctl epitopes correlated level viral replication single nucleotide mutation within immunodominant gag ctl epitope animal undetectable plasma viral rna resulted viral escape ctls burst viral replication clinical disease progression death aids-related complications data indicate viral escape ctl recognition may major limitation ctl-based aids vaccines likely administered large human populations next several years 
